Live bacteria for Cardiovascular Health
Cardiometabolic disorders are now understood as inflammatory conditions with microbial origins. Dysbiosis in the gut microbiome contributes to systemic inflammation, impaired lipid metabolism, and insulin resistance through the production of endotoxins such as lipopolysaccharides (LPS). A growing body of evidence demonstrates that targeted probiotic strains can help modulate these mechanisms — improving lipid profiles, enhancing bile acid metabolism, and lowering key markers of inflammation.
This webinar examines the mechanisms through which specific probiotic strains contribute to improved lipid profiles, reduced LDL oxidation, and enhanced bile acid metabolism.
Pain, Mood, and Sleep: Microbial Mediators and the gut-brain Axis
The relationship between the gut and brain is one of the most rapidly advancing areas in probiotic science. The gut microbiome influences neurotransmitter production, stress response, and inflammation — all key components of mental and emotional wellbeing.
This webinar explores how therapeutic bacteria can positively affect mood, resilience, and sleep via the microbiota–gut–brain axis. Attendees will gain insights into the role live bacteria can play in the management of pain and explore the evidence on their use in addressing anxiety, depression and sleep disturbance. We highlight a practical evidence-based approach to using specific live bacteria to support psychological wellbeing and mental resilience.
Oral Health and the Microbiome: A New Frontier
The oral cavity is home to a complex microbial community that plays a crucial role in both local and systemic health. In this webinar, we’ll examine how imbalances in the oral microbiome can influence dental health, inflammation and chronic disease. Learn about evidence-based probiotic interventions that restore microbial balance, support gum health, and contribute to systemic health outcomes.
Tags: cpd